首页> 外文OA文献 >EFFICACY OF SWITCHING ANTI VASCULAR ENDOTHELIAL GROWTH (A-VEGF) TO AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT WITH RANIBIZUMAB RESISTANCE

【2h】

EFFICACY OF SWITCHING ANTI VASCULAR ENDOTHELIAL GROWTH (A-VEGF) TO AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT WITH RANIBIZUMAB RESISTANCE

机译：用Ranibizumab抗性切换抗血管内皮生长（A-VEGF）在湿时期相关黄斑（AMD）处理中的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
E.V. Kozina; S.N. Sakhnov; A.G. Zabolotniy; V.V. Myasnikova; E.V. Bykova;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen [J] . Mantel Irmela, Dirani Ali, Zola Marta, Retina . 2019,第5期

机译：黄色萎缩性抗血管内皮生长因子治疗的新生血管年龄相关黄斑病毒变性风险因子评估，其根据观察和计划方案的ranibizumab或aflibercep的个性化治疗需要
2. Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments. [J] . Irene M Rusu, Avnish Deobhakta, Dan Yoon, Retina . 2014,第11期

机译：经过先前的抗血管内皮生长因子治疗后，患有新血管性年龄相关性黄斑变性的患者的眼内压转为abribercept注射。
3. Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments. [J] . Irene M Rusu, Avnish Deobhakta, Dan Yoon, Retina . 2014,第11期

机译：在先前的抗血管内皮生长因子治疗后，患有新生血管年龄相关性黄斑变性的患者的眼压转换为AFLIBERCEPT注射。
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Omega-3 Supplementation Combined With Anti–Vascular Endothelial Growth Factor Lowers Vitreal Levels of Vascular Endothelial Growth Factor in Wet Age-Related Macular Degeneration [O] . FLAVIO A. REZENDE, ERIC LAPALME, CYNTHIA X. QIAN, -1

机译：Omega-3补充剂与抗血管内皮生长因子联合降低湿性年龄相关性黄斑变性的玻璃体内血管内皮生长因子水平
7. PSS30 Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab [O] . Tempelaar S, Stephens S, Schouten J 2015

机译：PSS30在荷兰与年龄相关的湿性黄斑变性（Wamd）治疗的成本效益，玻璃体内阿柏西普（Ivt-Afl）和雷珠单抗的案例

EFFICACY OF SWITCHING ANTI VASCULAR ENDOTHELIAL GROWTH (A-VEGF) TO AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT WITH RANIBIZUMAB RESISTANCE

著录项

引文网络

相似文献

相关主题

期刊订阅